Ci Investments Inc. Vanda Pharmaceuticals Inc. Transaction History

Ci Investments Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$9.31 - $11.84 $87,709 - $111,544	-9,421 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$10.84 - $16.55 $102,123 - $155,917	9,421 New	9,421 $107,000
Q3 2021 Nov 12, 2021	SELL	$15.35 - $21.27 $217,862 - $301,885	-14,193 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$15.71 - $21.51 $222,972 - $305,291	14,193 New	14,193 $305,000

161

45.2M

165K

33.6K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $264M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Ci Investments Inc. with notifications on news.